BACLOFEN

BACLOFEN was reported 86631 times

BACLOFEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GAIT SPASTIC 131 0.3819
1 IMPLANT SITE EXTRAVASATION 225 0.2863
2 IMPLANT SITE EROSION 83 0.2823
3 NEEDLE FATIGUE 102 0.2232
4 MUSCLE SPASTICITY 2357 0.1916
5 DEVICE DAMAGE 140 0.1757
6 EPIDURAL LIPOMATOSIS 56 0.1628
7 RELAPSING-REMITTING MULTIPLE SCLEROSIS 138 0.1597
8 IMPLANT SITE INFECTION 348 0.1495
9 MEDICAL DEVICE SITE INFECTION 88 0.1417
10 CEREBROSPINAL FLUID LEAKAGE 206 0.1114
11 PROGRESSIVE MULTIPLE SCLEROSIS 111 0.0961
12 DEVICE BATTERY ISSUE 59 0.0897
13 IMPLANT SITE SWELLING 90 0.0883
14 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 165 0.0877
15 NEUROGENIC BLADDER 171 0.0809
16 SOFT TISSUE INJURY 59 0.0779
17 DEVICE INFUSION ISSUE 183 0.0737
18 JC POLYOMAVIRUS TEST POSITIVE 83 0.0709
19 DEVICE ALARM ISSUE 126 0.0693
20 JC VIRUS TEST POSITIVE 54 0.0641
21 BAND SENSATION 81 0.0638
22 CONSCIOUSNESS FLUCTUATING 65 0.0623
23 MONOPARESIS 112 0.0618
24 INFUSION SITE MASS 64 0.0589
25 CLONUS 158 0.0577
26 HYPERTONIC BLADDER 160 0.0553
27 PERONEAL NERVE PALSY 308 0.0541
28 B-LYMPHOCYTE COUNT DECREASED 72 0.0529
29 TRIGEMINAL NEURALGIA 209 0.0519
30 MULTIPLE SCLEROSIS RELAPSE 3430 0.0500
31 MULTIPLE SCLEROSIS 2347 0.0490
32 HYPERTONIA 281 0.0490
33 ELECTROENCEPHALOGRAM ABNORMAL 154 0.0487
34 LYMPHOCYTE PERCENTAGE DECREASED 61 0.0454
35 METABOLIC ENCEPHALOPATHY 135 0.0449
36 ENCEPHALOPATHY 1104 0.0449
37 AREFLEXIA 120 0.0449
38 NEUTROPHIL PERCENTAGE INCREASED 56 0.0444
39 TOXIC ENCEPHALOPATHY 222 0.0438
40 DECUBITUS ULCER 357 0.0438
41 CYSTITIS NONINFECTIVE 57 0.0424
42 HYPOTONIA 420 0.0420
43 PARAPARESIS 74 0.0415
44 RESPIRATORY DEPRESSION 492 0.0401
45 ENTHESOPATHY 61 0.0390
46 SPINAL CORD INJURY 68 0.0390
47 BRADYPNOEA 104 0.0385
48 WHITE BLOOD CELL COUNT ABNORMAL 242 0.0379
49 WOUND DEHISCENCE 128 0.0378
50 NO THERAPEUTIC RESPONSE 457 0.0374
51 IMPLANT SITE PAIN 166 0.0371
52 URINE ANALYSIS ABNORMAL 111 0.0371
53 WHITE BLOOD CELLS URINE POSITIVE 68 0.0361
54 HYPOREFLEXIA 69 0.0359
55 WHEELCHAIR USER 156 0.0351
56 CENTRAL NERVOUS SYSTEM LESION 473 0.0344
57 BLADDER SPASM 62 0.0331
58 DEVICE KINK 120 0.0329
59 AUTONOMIC NERVOUS SYSTEM IMBALANCE 96 0.0328
60 COMA SCALE ABNORMAL 95 0.0328
61 WALKING AID USER 215 0.0326
62 CERVICAL SPINAL STENOSIS 56 0.0325
63 DEVICE CONNECTION ISSUE 68 0.0322
64 RADICULOPATHY 84 0.0318
65 MUSCLE CONTRACTURE 64 0.0315
66 DYSAESTHESIA 96 0.0313
67 SCOLIOSIS 191 0.0308
68 SEDATION COMPLICATION 78 0.0305
69 ESCHERICHIA URINARY TRACT INFECTION 129 0.0303
70 COMA 1422 0.0298
71 MENTAL STATUS CHANGES 824 0.0296
72 MUSCLE TIGHTNESS 479 0.0295
73 BLADDER DISORDER 291 0.0293
74 QUADRIPLEGIA 60 0.0291
75 JOINT NOISE 57 0.0290
76 MICTURITION URGENCY 329 0.0288
77 HYPERPARATHYROIDISM SECONDARY 72 0.0287
78 LOSS OF CONTROL OF LEGS 105 0.0277
79 DECREASED INTEREST 162 0.0274
80 ATAXIA 324 0.0273
81 PNEUMONIA ASPIRATION 681 0.0272
82 NEPHROGENIC ANAEMIA 124 0.0267
83 INTERVERTEBRAL DISC DISORDER 114 0.0267
84 URINARY TRACT INFECTION BACTERIAL 67 0.0265
85 UROSEPSIS 243 0.0263
86 BACTERIAL TEST POSITIVE 57 0.0255
87 MEDICAL DEVICE DISCOMFORT 78 0.0255
88 REBOUND ACID HYPERSECRETION 77 0.0254
89 DEVICE FAILURE 386 0.0253
90 MYOCLONUS 301 0.0252
91 NEURALGIA 610 0.0251
92 UNRESPONSIVE TO STIMULI 636 0.0246
93 BLOOD IMMUNOGLOBULIN G DECREASED 61 0.0246
94 DELIRIUM 848 0.0244
95 BALANCE DISORDER 2092 0.0242
96 LYMPHOCYTE COUNT DECREASED 422 0.0238
97 PERFORMANCE STATUS DECREASED 111 0.0238
98 JUVENILE IDIOPATHIC ARTHRITIS 58 0.0237
99 URINARY INCONTINENCE 698 0.0235
100 TEMPERATURE INTOLERANCE 243 0.0235
101 NEUROLOGICAL DECOMPENSATION 54 0.0233
102 SUSPECTED SUICIDE 109 0.0232
103 CLUMSINESS 62 0.0227
104 HYPERREFLEXIA 79 0.0227
105 PERSONALITY DISORDER 59 0.0225
106 ANAL INCONTINENCE 200 0.0222
107 SKIN ABRASION 105 0.0222
108 CONCUSSION 171 0.0221
109 HOSTILITY 56 0.0220
110 LIPOMA 57 0.0220
111 MOTOR DYSFUNCTION 224 0.0220
112 STATUS EPILEPTICUS 248 0.0219
113 LUMBAR SPINAL STENOSIS 64 0.0219
114 NYSTAGMUS 116 0.0218
115 SLEEP APNOEA SYNDROME 417 0.0218
116 PARAPLEGIA 63 0.0218
117 GAIT DISTURBANCE 4174 0.0218
118 HYPOKINESIA 315 0.0217
119 MONOPLEGIA 93 0.0214
120 RESPIRATORY ACIDOSIS 84 0.0213
121 WRONG PATIENT RECEIVED PRODUCT 62 0.0212
122 PRE-EXISTING CONDITION IMPROVED 132 0.0211
123 INTERVERTEBRAL DISC DEGENERATION 195 0.0211
124 MUSCLE RIGIDITY 251 0.0210
125 MUSCULAR WEAKNESS 2381 0.0209
126 URINARY TRACT INFECTION 3565 0.0209
127 VITAMIN D DEFICIENCY 203 0.0208
128 RESPIRATORY RATE DECREASED 65 0.0207
129 SENSORY LOSS 166 0.0206
130 FAECAL INCONTINENCE 99 0.0206
131 MUSCLE CONTRACTIONS INVOLUNTARY 72 0.0205
132 HALLUCINATIONS, MIXED 86 0.0204
133 DEMYELINATION 83 0.0202
134 DYSGRAPHIA 133 0.0202
135 ABASIA 497 0.0201
136 INCONTINENCE 212 0.0200
137 FINE MOTOR SKILL DYSFUNCTION 58 0.0200
138 DRUG WITHDRAWAL SYNDROME 1739 0.0198
139 OPTIC NEURITIS 180 0.0198
140 INCOHERENT 128 0.0198
141 COMPLICATION ASSOCIATED WITH DEVICE 284 0.0195
142 NEUROTOXICITY 342 0.0195
143 SNORING 72 0.0190
144 COORDINATION ABNORMAL 263 0.0188
145 POSTURE ABNORMAL 61 0.0187
146 HYPOVENTILATION 61 0.0187
147 SPINAL OSTEOARTHRITIS 164 0.0186
148 URINARY TRACT DISORDER 84 0.0186
149 SEDATION 483 0.0184
150 MUSCLE SPASMS 3383 0.0184
151 MOBILITY DECREASED 1323 0.0184
152 SPINAL FUSION SURGERY 74 0.0182
153 POISONING DELIBERATE 172 0.0181
154 DYSSTASIA 525 0.0180
155 HAEMOGLOBIN INCREASED 82 0.0180
156 THERAPY CESSATION 920 0.0179
157 INTERVERTEBRAL DISC PROTRUSION 388 0.0177
158 FUNCTIONAL GASTROINTESTINAL DISORDER 61 0.0176
159 MUSCULOSKELETAL STIFFNESS 1545 0.0176
160 HYPOTHERMIA 178 0.0176
161 SENSORY DISTURBANCE 282 0.0176
162 COMPLETED SUICIDE 1459 0.0175
163 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 58 0.0175
164 WITHDRAWAL SYNDROME 733 0.0174
165 CYSTITIS 547 0.0172
166 SPINAL COLUMN STENOSIS 81 0.0171
167 RED CELL DISTRIBUTION WIDTH INCREASED 71 0.0171
168 HEMIPARESIS 284 0.0167
169 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 138 0.0167
170 SPINAL STENOSIS 69 0.0167
171 FALL 5539 0.0166
172 BURSITIS 201 0.0166
173 PARALYSIS 237 0.0165
174 NERVE COMPRESSION 152 0.0165
175 MOVEMENT DISORDER 517 0.0161
176 URINARY RETENTION 533 0.0160
177 HYPOAESTHESIA 2384 0.0159
178 THYROID MASS 61 0.0159
179 FEELING OF BODY TEMPERATURE CHANGE 93 0.0159
180 COLITIS MICROSCOPIC 75 0.0158
181 HYPERAESTHESIA 130 0.0158
182 MENINGITIS 105 0.0157
183 EAR PRURITUS 55 0.0157
184 POST-TRAUMATIC STRESS DISORDER 105 0.0157
185 KLEBSIELLA INFECTION 79 0.0156
186 MUSCLE TWITCHING 359 0.0156
187 FLUSHING 1582 0.0155
188 DYSTONIA 301 0.0155
189 VULVOVAGINAL MYCOTIC INFECTION 61 0.0155
190 ROTATOR CUFF SYNDROME 199 0.0155
191 ANKLE FRACTURE 239 0.0154
192 URINE ABNORMALITY 70 0.0154
193 MAJOR DEPRESSION 112 0.0153
194 LOGORRHOEA 54 0.0153
195 SINUS BRADYCARDIA 148 0.0153
196 DEPRESSED LEVEL OF CONSCIOUSNESS 605 0.0153
197 APNOEA 119 0.0153
198 GRAND MAL CONVULSION 141 0.0153
199 TENDERNESS 156 0.0150
200 MIOSIS 119 0.0148
201 PRODUCT ADMINISTRATION INTERRUPTED 116 0.0148
202 BEDRIDDEN 194 0.0147
203 FACE INJURY 56 0.0147
204 LIMB DISCOMFORT 456 0.0147
205 MEMORY IMPAIRMENT 2020 0.0147
206 EUPHORIC MOOD 150 0.0146
207 DYSARTHRIA 551 0.0146
208 SPINAL PAIN 171 0.0146
209 NOCTURIA 177 0.0146
210 CEREBRAL ATROPHY 58 0.0145
211 DIPLOPIA 375 0.0144
212 GASTROINTESTINAL MOTILITY DISORDER 77 0.0144
213 ARTERIOSCLEROSIS CORONARY ARTERY 95 0.0143
214 CEREBRAL DISORDER 106 0.0143
215 TIBIA FRACTURE 67 0.0143
216 COGNITIVE DISORDER 666 0.0142
217 SEIZURE 1630 0.0141
218 BRUXISM 76 0.0141
219 LYMPHOPENIA 199 0.0141
220 SOMNOLENCE 2799 0.0139
221 GENERALISED TONIC-CLONIC SEIZURE 229 0.0138
222 MUSCULOSKELETAL DISORDER 263 0.0138
223 SPINAL OPERATION 170 0.0138
224 PARTIAL SEIZURES 72 0.0137
225 IMMOBILE 60 0.0137
226 SPINAL DISORDER 130 0.0137
227 MUSCLE FATIGUE 58 0.0137
228 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 68 0.0136
229 URINE ODOUR ABNORMAL 80 0.0136
230 ASPHYXIA 111 0.0136
231 VITAMIN B12 DEFICIENCY 55 0.0136
232 ATELECTASIS 131 0.0135
233 BACK DISORDER 218 0.0134
234 FIBROMYALGIA 324 0.0133
235 RESTLESS LEGS SYNDROME 242 0.0133
236 DYSKINESIA 540 0.0133
237 IMPAIRED GASTRIC EMPTYING 181 0.0133
238 MUSCLE ATROPHY 168 0.0132
239 FACIAL PAIN 118 0.0132
240 SKIN LACERATION 143 0.0131
241 GAIT INABILITY 438 0.0131
242 HYPERTHERMIA 100 0.0131
243 FOOT FRACTURE 248 0.0131
244 INFLUENZA LIKE ILLNESS 1074 0.0130
245 DEVICE OCCLUSION 183 0.0130
246 EYE MOVEMENT DISORDER 89 0.0130
247 HYPERAMMONAEMIA 65 0.0130
248 VITAMIN D DECREASED 111 0.0130
249 RENAL CYST 103 0.0130
250 CATATONIA 68 0.0129
251 BRAIN INJURY 129 0.0129
252 HEMIPLEGIA 107 0.0128
253 NERVE INJURY 143 0.0128
254 TOXICITY TO VARIOUS AGENTS 2160 0.0128
255 NEPHROLITHIASIS 586 0.0128
256 SEASONAL ALLERGY 180 0.0127
257 OBESITY 201 0.0126
258 BODY TEMPERATURE INCREASED 256 0.0125
259 SCIATICA 200 0.0125
260 HEAD INJURY 397 0.0125
261 ONYCHOMYCOSIS 55 0.0125
262 ALTERED STATE OF CONSCIOUSNESS 271 0.0125
263 LOWER LIMB FRACTURE 240 0.0125
264 NECK PAIN 691 0.0124
265 HICCUPS 101 0.0123
266 RIB FRACTURE 252 0.0122
267 HYPERVENTILATION 71 0.0122
268 NEUROLOGICAL SYMPTOM 70 0.0122
269 HYPERSOMNIA 351 0.0122
270 BRADYCARDIA 645 0.0121
271 LETHARGY 697 0.0121
272 VAGINAL INFECTION 57 0.0121
273 CONVULSION 691 0.0121
274 SPEECH DISORDER 631 0.0120
275 LIGAMENT SPRAIN 119 0.0120
276 POLLAKIURIA 500 0.0120
277 CHRONIC KIDNEY DISEASE 908 0.0119
278 DIABETIC NEUROPATHY 59 0.0119
279 STAPHYLOCOCCAL INFECTION 393 0.0119
280 RESPIRATORY ARREST 327 0.0119
281 FAECALOMA 65 0.0119
282 LYMPHOEDEMA 82 0.0118
283 FEELING DRUNK 88 0.0118
284 DISORIENTATION 466 0.0117
285 END STAGE RENAL DISEASE 213 0.0117
286 POOR QUALITY SLEEP 251 0.0116
287 PERIPHERAL COLDNESS 160 0.0116
288 MIGRAINE 1109 0.0116
289 THERAPEUTIC RESPONSE UNEXPECTED 521 0.0116
290 WOUND INFECTION 127 0.0116
291 TREMOR 1923 0.0116
292 GASTROOESOPHAGEAL REFLUX DISEASE 928 0.0115
293 APHASIA 346 0.0114
294 SEROTONIN SYNDROME 220 0.0114
295 ASPIRATION 125 0.0114
296 HAND FRACTURE 80 0.0113
297 SOMNAMBULISM 74 0.0113
298 MENISCUS INJURY 69 0.0112
299 PARAESTHESIA 1760 0.0112
300 INTENTIONAL OVERDOSE 717 0.0112
301 HEPATIC STEATOSIS 207 0.0111
302 INITIAL INSOMNIA 114 0.0111
303 POSTOPERATIVE WOUND INFECTION 75 0.0111
304 POST PROCEDURAL INFECTION 90 0.0111
305 NEUROLEPTIC MALIGNANT SYNDROME 131 0.0110
306 CONFUSIONAL STATE 1784 0.0110
307 BURNING SENSATION 772 0.0110
308 CARPAL TUNNEL SYNDROME 154 0.0110
309 KIDNEY INFECTION 215 0.0109
310 DEPRESSION 2485 0.0109
311 MEDICAL DEVICE COMPLICATION 80 0.0108
312 BACK PAIN 2513 0.0108
313 ACTIVITIES OF DAILY LIVING IMPAIRED 213 0.0107
314 MUSCLE DISORDER 87 0.0107
315 GRIP STRENGTH DECREASED 94 0.0107
316 BLOOD PRESSURE SYSTOLIC INCREASED 208 0.0107
317 FORMICATION 74 0.0106
318 COVID-19 PNEUMONIA 125 0.0106
319 HALLUCINATION, VISUAL 223 0.0106
320 PRESCRIBED UNDERDOSE 210 0.0105
321 INGUINAL HERNIA 64 0.0105
322 ACUTE RESPIRATORY FAILURE 202 0.0105
323 HAEMODYNAMIC INSTABILITY 80 0.0105
324 AMNESIA 680 0.0104
325 ROAD TRAFFIC ACCIDENT 436 0.0104
326 JOINT DISLOCATION 110 0.0104
327 HALLUCINATION 784 0.0104
328 IMPAIRED DRIVING ABILITY 117 0.0103
329 INSOMNIA 2728 0.0102
330 MUSCULOSKELETAL DISCOMFORT 176 0.0102
331 INCREASED TENDENCY TO BRUISE 94 0.0102
332 DYSURIA 376 0.0102
333 CLOSTRIDIUM DIFFICILE COLITIS 108 0.0102
334 AFFECTIVE DISORDER 80 0.0102
335 PHOTOPSIA 64 0.0101
336 AGITATION 743 0.0101
337 BLOOD POTASSIUM DECREASED 304 0.0101
338 BRADYPHRENIA 66 0.0101
339 CONCOMITANT DISEASE AGGRAVATED 62 0.0100
340 PARANOIA 173 0.0100
341 OSTEOARTHRITIS 425 0.0100
342 CELLULITIS 504 0.0100
343 ORAL HERPES 195 0.0100
344 IMMUNOSUPPRESSION 88 0.0100
345 JOINT INJURY 213 0.0100
346 DEVICE RELATED INFECTION 153 0.0099
347 THYROID DISORDER 153 0.0099
348 DYSPHAGIA 942 0.0099
349 HYDROCEPHALUS 54 0.0099
350 LIMB INJURY 269 0.0099
351 INADEQUATE ANALGESIA 84 0.0099
352 BRAIN FOG 154 0.0098
353 MUSCLE STRAIN 85 0.0098
354 BLOOD MAGNESIUM DECREASED 84 0.0097
355 HERPES VIRUS INFECTION 56 0.0097
356 PHARYNGEAL SWELLING 95 0.0097
357 FEELING HOT 595 0.0097
358 DISTURBANCE IN ATTENTION 523 0.0097
359 MIDDLE INSOMNIA 181 0.0097
360 LOSS OF CONSCIOUSNESS 1239 0.0097
361 HEART RATE DECREASED 339 0.0096
362 OSTEOMYELITIS 173 0.0095
363 SUPRAVENTRICULAR TACHYCARDIA 91 0.0095
364 HAEMATOCRIT DECREASED 188 0.0095
365 CANDIDA INFECTION 160 0.0095
366 EAR INFECTION 252 0.0095
367 PAIN 5802 0.0094
368 POST PROCEDURAL COMPLICATION 181 0.0094
369 HIP FRACTURE 303 0.0094
370 SCAR 160 0.0093
371 WRIST FRACTURE 112 0.0093
372 GENERAL SYMPTOM 70 0.0093
373 SPINAL COMPRESSION FRACTURE 77 0.0093
374 MULTIPLE ALLERGIES 73 0.0093
375 SKIN REACTION 131 0.0093
376 ASTHENIA 3488 0.0093
377 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 443 0.0092
378 PSEUDOMONAS INFECTION 79 0.0092
379 BLEPHAROSPASM 58 0.0092
380 PULMONARY CONGESTION 121 0.0092
381 CONTUSION 881 0.0091
382 SINUS DISORDER 181 0.0091
383 HYPERHIDROSIS 1177 0.0091
384 PROCEDURAL COMPLICATION 70 0.0091
385 PAIN IN EXTREMITY 2688 0.0091
386 BRONCHITIS 673 0.0091
387 NEUTROPHIL COUNT INCREASED 93 0.0091
388 THERAPY NON-RESPONDER 407 0.0090
389 GASTROINTESTINAL INFECTION 80 0.0089
390 BACK INJURY 97 0.0089
391 MENTAL IMPAIRMENT 216 0.0089
392 OSTEOPENIA 135 0.0089
393 ESCHERICHIA INFECTION 73 0.0089
394 TENDONITIS 137 0.0088
395 BIPOLAR DISORDER 96 0.0088
396 DROOLING 61 0.0088
397 RESPIRATORY FAILURE 643 0.0088
398 POISONING 110 0.0087
399 FEELING COLD 243 0.0087
400 HYPERLIPIDAEMIA 104 0.0087
401 OSTEOPOROSIS 357 0.0087
402 ECONOMIC PROBLEM 131 0.0086
403 GASTROENTERITIS VIRAL 156 0.0086
404 MANIA 142 0.0086
405 COVID-19 1513 0.0086
406 UTERINE LEIOMYOMA 63 0.0086
407 RESPIRATION ABNORMAL 59 0.0086
408 SLEEP DISORDER 604 0.0085
409 GROIN PAIN 75 0.0085
410 BODY HEIGHT DECREASED 91 0.0085
411 RESPIRATORY DISTRESS 234 0.0085
412 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 464 0.0084
413 RESPIRATORY RATE INCREASED 75 0.0084
414 UPPER RESPIRATORY TRACT INFECTION 388 0.0084
415 DEPRESSED MOOD 443 0.0084
416 HERPES ZOSTER 480 0.0083
417 CONSTIPATION 1819 0.0083
418 PRODUCT DOSE OMISSION 544 0.0083
419 EXOSTOSIS 76 0.0083
420 IMMUNODEFICIENCY 124 0.0083
421 OVERDOSE 1794 0.0083
422 DELUSION 129 0.0083
423 SEPSIS 926 0.0083
424 PSYCHOTIC DISORDER 245 0.0083
425 SKIN INFECTION 93 0.0083
426 MUSCULOSKELETAL PAIN 434 0.0083
427 THERAPEUTIC RESPONSE DECREASED 501 0.0083
428 SUICIDE ATTEMPT 499 0.0082
429 MASS 115 0.0082
430 LACERATION 77 0.0082
431 LOCALISED INFECTION 198 0.0082
432 FATIGUE 6341 0.0081
433 MYDRIASIS 104 0.0081
434 DENTAL CARIES 89 0.0080
435 SARS-COV-2 TEST POSITIVE 106 0.0080
436 DEVICE DISLOCATION 348 0.0080
437 TOOTH INFECTION 105 0.0080
438 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 136 0.0079
439 CONDITION AGGRAVATED 2410 0.0079
440 LEUKOCYTOSIS 143 0.0079
441 FLANK PAIN 74 0.0079
442 MUSCULOSKELETAL CHEST PAIN 122 0.0079
443 BLOOD PRESSURE DIASTOLIC DECREASED 58 0.0078
444 DECREASED IMMUNE RESPONSIVENESS 77 0.0078
445 PELVIC FRACTURE 61 0.0078
446 HYPOAESTHESIA ORAL 118 0.0078
447 BLOOD SODIUM DECREASED 147 0.0078
448 FEELING ABNORMAL 1866 0.0078
449 UPPER LIMB FRACTURE 155 0.0078
450 SPINAL FRACTURE 155 0.0077
451 TACHYCARDIA 687 0.0077
452 LABORATORY TEST ABNORMAL 228 0.0077
453 DRUG SCREEN POSITIVE 61 0.0077
454 ANXIETY 2193 0.0077
455 FURUNCLE 61 0.0077
456 IRRITABLE BOWEL SYNDROME 165 0.0077
457 SINUSITIS 788 0.0077
458 CHILLS 901 0.0077
459 VERTIGO 467 0.0077
460 HIATUS HERNIA 99 0.0076
461 BLOOD URINE PRESENT 145 0.0076
462 VIRAL INFECTION 254 0.0076
463 TROPONIN INCREASED 58 0.0076
464 THINKING ABNORMAL 142 0.0076
465 PYELONEPHRITIS 66 0.0076
466 SALIVARY HYPERSECRETION 76 0.0076
467 INFUSION SITE ERYTHEMA 64 0.0076
468 HYPERTENSION 1608 0.0076
469 BOWEL MOVEMENT IRREGULARITY 58 0.0076
470 EAR PAIN 147 0.0076
471 CARDIOMEGALY 93 0.0076
472 EPILEPSY 231 0.0075
473 INFUSION SITE PAIN 97 0.0075
474 RED BLOOD CELL SEDIMENTATION RATE INCREASED 83 0.0075
475 AFFECT LABILITY 72 0.0075
476 SLUGGISHNESS 76 0.0074
477 POOR VENOUS ACCESS 77 0.0074
478 TOOTH FRACTURE 82 0.0074
479 UNEVALUABLE EVENT 562 0.0074
480 FRUSTRATION TOLERANCE DECREASED 60 0.0074
481 TINNITUS 341 0.0074
482 HEART RATE INCREASED 734 0.0074
483 PANIC ATTACK 270 0.0074
484 SCRATCH 78 0.0074
485 PHOTOPHOBIA 139 0.0074
486 HYSTERECTOMY 64 0.0074
487 PRODUCT PRESCRIBING ERROR 176 0.0074
488 IMMUNE SYSTEM DISORDER 97 0.0074
489 CRYING 267 0.0073
490 FEEDING DISORDER 149 0.0073
491 DRY MOUTH 596 0.0073
492 CARDIO-RESPIRATORY ARREST 307 0.0073
493 RENAL INJURY 218 0.0073
494 WOUND 205 0.0073
495 DIZZINESS 3656 0.0073
496 ACCIDENTAL OVERDOSE 268 0.0073
497 INFLUENZA 817 0.0073
498 WHITE BLOOD CELL COUNT INCREASED 281 0.0073
499 JOINT STIFFNESS 192 0.0073
500 BODY TEMPERATURE DECREASED 72 0.0073
501 BLOOD ALBUMIN DECREASED 58 0.0073
502 WHITE BLOOD CELL COUNT DECREASED 791 0.0073
503 VISION BLURRED 1001 0.0073
504 GASTRIC DISORDER 250 0.0073
505 CLOSTRIDIUM DIFFICILE INFECTION 159 0.0073
506 PNEUMONIA 2357 0.0073
507 CHOKING 142 0.0073
508 DRUG TOXICITY 99 0.0073
509 CHROMATURIA 164 0.0073
510 BLOOD PRESSURE FLUCTUATION 174 0.0072
511 HIP ARTHROPLASTY 111 0.0072
512 JOINT RANGE OF MOTION DECREASED 97 0.0072
513 ARTHRITIS 568 0.0072
514 COLD SWEAT 127 0.0072
515 ACCIDENT 86 0.0072
516 HEADACHE 4504 0.0072
517 DIVERTICULITIS 199 0.0072
518 CYST 89 0.0072
519 GLAUCOMA 138 0.0072
520 VISUAL IMPAIRMENT 886 0.0071
521 FOOT DEFORMITY 79 0.0071
522 BLOOD CALCIUM DECREASED 80 0.0071
523 EAR DISCOMFORT 73 0.0071
524 NIGHTMARE 246 0.0071
525 CONTRAINDICATED PRODUCT ADMINISTERED 215 0.0071
526 WEIGHT FLUCTUATION 74 0.0071
527 RESPIRATORY DISORDER 211 0.0070
528 HYPOTHYROIDISM 225 0.0070
529 ABNORMAL BEHAVIOUR 279 0.0070
530 FACIAL PARALYSIS 60 0.0070
531 HOT FLUSH 529 0.0070
532 PSYCHOMOTOR HYPERACTIVITY 116 0.0070
533 DRY THROAT 71 0.0070
534 CHOLELITHIASIS 229 0.0070
535 ANKYLOSING SPONDYLITIS 92 0.0070
536 AUTOIMMUNE DISORDER 68 0.0070
537 IMPAIRED HEALING 229 0.0070
538 POLYURIA 57 0.0070
539 HEAD DISCOMFORT 123 0.0069
540 ERECTILE DYSFUNCTION 178 0.0069
541 HALLUCINATION, AUDITORY 110 0.0069
542 INFECTION 1002 0.0069
543 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 61 0.0069
544 RENAL PAIN 73 0.0069
545 OXYGEN SATURATION DECREASED 387 0.0069
546 BACTERIAL INFECTION 128 0.0069
547 RED BLOOD CELL COUNT DECREASED 196 0.0068
548 CORONARY ARTERY OCCLUSION 94 0.0068
549 DRUG INTERACTION 1086 0.0068
550 DRUG LEVEL INCREASED 113 0.0068
551 THROAT IRRITATION 305 0.0068
552 TOOTHACHE 123 0.0068
553 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 482 0.0068
554 OROPHARYNGEAL PAIN 626 0.0068
555 NERVOUS SYSTEM DISORDER 211 0.0068
556 RETCHING 144 0.0067
557 NEUROPATHY PERIPHERAL 641 0.0067
558 IRRITABILITY 405 0.0067
559 PERIPHERAL SWELLING 1036 0.0067
560 IRON DEFICIENCY ANAEMIA 62 0.0067
561 MENTAL DISORDER 292 0.0067
562 BLOOD PRESSURE DECREASED 445 0.0067
563 HYPOTENSION 1342 0.0067
564 UPPER-AIRWAY COUGH SYNDROME 55 0.0067
565 RESPIRATORY TRACT CONGESTION 106 0.0067
566 FUNGAL INFECTION 222 0.0067
567 BACTERAEMIA 79 0.0066
568 TOOTH DISORDER 148 0.0066
569 ACUTE KIDNEY INJURY 1017 0.0066
570 BLOOD PRESSURE ABNORMAL 132 0.0066
571 HEPATIC ENZYME INCREASED 452 0.0066
572 HAEMORRHOIDS 129 0.0066
573 ABNORMAL DREAMS 182 0.0066
574 SMALL INTESTINAL OBSTRUCTION 81 0.0066
575 NIGHT SWEATS 212 0.0066
576 HYPOPHAGIA 168 0.0066
577 CHOLECYSTECTOMY 75 0.0066
578 RESTLESSNESS 240 0.0066
579 CARDIAC ARREST 541 0.0065
580 TRANSIENT ISCHAEMIC ATTACK 221 0.0065
581 WEIGHT DECREASED 1825 0.0065
582 MALNUTRITION 73 0.0065
583 BLINDNESS UNILATERAL 92 0.0065
584 NASOPHARYNGITIS 1202 0.0065
585 APHONIA 91 0.0065
586 HYPOXIA 229 0.0065
587 SURGERY 381 0.0065
588 DISABILITY 128 0.0065
589 TACHYPNOEA 88 0.0065
590 GASTRITIS 170 0.0065
591 MITRAL VALVE INCOMPETENCE 73 0.0064
592 ORAL PAIN 144 0.0064
593 RESPIRATORY TRACT INFECTION 167 0.0064
594 BASAL CELL CARCINOMA 100 0.0064
595 THERAPY CHANGE 63 0.0064
596 URINE OUTPUT DECREASED 56 0.0064
597 BLOOD PRESSURE INCREASED 979 0.0064
598 DYSPEPSIA 628 0.0064
599 PYREXIA 2208 0.0064
600 PHARYNGITIS STREPTOCOCCAL 69 0.0064
601 PRODUCT DOSE OMISSION IN ERROR 180 0.0064
602 BRAIN OEDEMA 80 0.0063
603 APPENDICITIS 59 0.0063
604 CHOLECYSTITIS 75 0.0063
605 SINUS CONGESTION 85 0.0063
606 TOOTH ABSCESS 64 0.0063
607 DRUG DOSE OMISSION 1038 0.0063
608 OEDEMA PERIPHERAL 764 0.0063
609 LIVER FUNCTION TEST ABNORMAL 182 0.0063
610 VOMITING 2934 0.0062
611 APATHY 91 0.0062
612 SUICIDAL IDEATION 569 0.0062
613 DEHYDRATION 829 0.0062
614 ALOPECIA 1218 0.0062
615 KNEE OPERATION 61 0.0062
616 SKIN ULCER 160 0.0062
617 SINUS TACHYCARDIA 87 0.0061
618 ELECTROLYTE IMBALANCE 71 0.0061
619 FEMUR FRACTURE 189 0.0061
620 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 317 0.0061
621 FULL BLOOD COUNT ABNORMAL 64 0.0060
622 ANHEDONIA 159 0.0060
623 DERMATITIS CONTACT 69 0.0060
624 BLOOD CHOLESTEROL INCREASED 282 0.0060
625 DEEP VEIN THROMBOSIS 392 0.0060
626 HYPOKALAEMIA 278 0.0060
627 NAUSEA 4759 0.0060
628 SUBDURAL HAEMATOMA 86 0.0060
629 EYE PAIN 338 0.0060
630 KNEE ARTHROPLASTY 126 0.0060
631 BLOOD UREA INCREASED 100 0.0060
632 NASAL CONGESTION 350 0.0059
633 DEVICE MALFUNCTION 418 0.0059
634 RHINORRHOEA 384 0.0059
635 UNDERDOSE 433 0.0059
636 ELECTROCARDIOGRAM QT PROLONGED 213 0.0059
637 ABDOMINAL DISCOMFORT 993 0.0059
638 COELIAC DISEASE 58 0.0059
639 RENAL TUBULAR NECROSIS 58 0.0059
640 ABDOMINAL PAIN UPPER 1217 0.0059
641 HAEMATOMA 153 0.0059
642 SPUTUM DISCOLOURED 56 0.0059
643 MYALGIA 1002 0.0059
644 SPLENOMEGALY 69 0.0059
645 CHEST PAIN 1090 0.0059
646 ARTHROPATHY 327 0.0059
647 OEDEMA 319 0.0059
648 DIZZINESS POSTURAL 57 0.0059
649 HAEMATEMESIS 149 0.0059
650 HOSPICE CARE 58 0.0059
651 DRUG EFFECT LESS THAN EXPECTED 87 0.0059
652 TUBULOINTERSTITIAL NEPHRITIS 110 0.0059
653 ORAL CANDIDIASIS 77 0.0058
654 PETECHIAE 61 0.0058
655 RENAL FAILURE 774 0.0058
656 RHEUMATOID ARTHRITIS 661 0.0058
657 PERSONALITY CHANGE 54 0.0058
658 DRUG EFFECT DECREASED 313 0.0058
659 HEART RATE IRREGULAR 131 0.0058
660 INFLAMMATION 299 0.0058
661 NEPHROPATHY 54 0.0058
662 PULMONARY THROMBOSIS 63 0.0058
663 INTESTINAL OBSTRUCTION 217 0.0058
664 PAIN IN JAW 163 0.0057
665 SNEEZING 129 0.0057
666 DECREASED ACTIVITY 62 0.0057
667 FLUID RETENTION 292 0.0057
668 PRESCRIBED OVERDOSE 111 0.0057
669 BLOOD IRON DECREASED 68 0.0057
670 ILLNESS 590 0.0057
671 SCAB 65 0.0057
672 ARTHRALGIA 2369 0.0057
673 GASTROINTESTINAL DISORDER 510 0.0057
674 MALAISE 2494 0.0057
675 FEELING JITTERY 108 0.0057
676 RHABDOMYOLYSIS 236 0.0057
677 SWELLING 529 0.0056
678 INJECTION SITE MASS 209 0.0056
679 WEIGHT INCREASED 1263 0.0056
680 EATING DISORDER 120 0.0056
681 CHEST DISCOMFORT 576 0.0056
682 PULMONARY EMBOLISM 534 0.0056
683 DRUG INTOLERANCE 542 0.0056
684 OVARIAN CYST 56 0.0056
685 MALIGNANT MELANOMA 75 0.0056
686 SUBARACHNOID HAEMORRHAGE 57 0.0056
687 AGGRESSION 280 0.0056
688 THERAPEUTIC RESPONSE SHORTENED 185 0.0056
689 PALPITATIONS 653 0.0056
690 ORTHOSTATIC HYPOTENSION 97 0.0056
691 IMPAIRED WORK ABILITY 119 0.0056
692 IMPAIRED QUALITY OF LIFE 80 0.0056
693 JOINT SWELLING 668 0.0055
694 ULCER 88 0.0055
695 INFUSION RELATED REACTION 364 0.0055
696 EYE INFECTION 62 0.0055
697 MOOD SWINGS 175 0.0055
698 PHARYNGITIS 68 0.0055
699 DYSPHONIA 320 0.0055
700 DRY EYE 273 0.0055
701 SYNCOPE 547 0.0055
702 GASTROINTESTINAL PAIN 60 0.0054
703 BONE DISORDER 99 0.0054
704 INSURANCE ISSUE 83 0.0054
705 HYPONATRAEMIA 305 0.0054
706 BLOOD TEST ABNORMAL 76 0.0054
707 CIRCULATORY COLLAPSE 92 0.0054
708 DRUG ABUSE 449 0.0054
709 ILEUS 67 0.0054
710 GALLBLADDER DISORDER 96 0.0054
711 INTENTIONAL PRODUCT USE ISSUE 469 0.0053
712 EMPHYSEMA 54 0.0053
713 DERMATITIS ALLERGIC 67 0.0053
714 TYPE 2 DIABETES MELLITUS 179 0.0053
715 INTENTIONAL PRODUCT MISUSE 465 0.0053
716 PULMONARY MASS 79 0.0053
717 QUALITY OF LIFE DECREASED 71 0.0053
718 INJECTION SITE REACTION 364 0.0053
719 THROAT TIGHTNESS 143 0.0053
720 DISCOMFORT 322 0.0053
721 BLOOD ALKALINE PHOSPHATASE INCREASED 131 0.0053
722 GASTRIC ULCER 100 0.0053
723 BLOOD CREATINE PHOSPHOKINASE INCREASED 151 0.0052
724 OESOPHAGITIS 57 0.0052
725 ABSCESS 83 0.0052
726 THROMBOSIS 418 0.0052
727 NERVOUSNESS 271 0.0052
728 ADVERSE DRUG REACTION 465 0.0052
729 INJECTION SITE HAEMATOMA 75 0.0052
730 FEAR 139 0.0052
731 BLINDNESS 210 0.0051
732 CARDIOMYOPATHY 76 0.0051
733 ANGER 172 0.0051
734 SKIN LESION 139 0.0051
735 LYMPHADENOPATHY 179 0.0051
736 EYE DISORDER 166 0.0050
737 SEPTIC SHOCK 219 0.0050
738 INJECTION SITE INDURATION 65 0.0050
739 ABDOMINAL DISTENSION 523 0.0050
740 COUGH 1403 0.0050
741 LIVER FUNCTION TEST INCREASED 107 0.0050
742 EMOTIONAL DISORDER 153 0.0050
743 HYPERSENSITIVITY 920 0.0050
744 PRURITUS 1904 0.0049
745 ALANINE AMINOTRANSFERASE INCREASED 304 0.0049
746 TENDON RUPTURE 61 0.0049
747 SYNOVITIS 89 0.0049
748 STOMATITIS 299 0.0049
749 DIARRHOEA 3182 0.0049
750 PRODUCTIVE COUGH 235 0.0049
751 DIABETES MELLITUS 375 0.0049
752 HERNIA 95 0.0049
753 C-REACTIVE PROTEIN INCREASED 178 0.0049
754 FLATULENCE 277 0.0049
755 INJECTION SITE DISCOLOURATION 61 0.0049
756 HAND DEFORMITY 64 0.0049
757 THERAPEUTIC PRODUCT EFFECT DECREASED 218 0.0049
758 SWOLLEN TONGUE 152 0.0049
759 TREATMENT NONCOMPLIANCE 266 0.0049
760 OBSTRUCTIVE AIRWAYS DISORDER 54 0.0048
761 SKIN DISCOLOURATION 223 0.0048
762 DYSPNOEA 2734 0.0048
763 PRODUCT DOSE OMISSION ISSUE 1420 0.0048
764 WHEEZING 286 0.0048
765 LOCAL SWELLING 84 0.0048
766 BLOOD TRIGLYCERIDES INCREASED 85 0.0048
767 PHARYNGEAL OEDEMA 74 0.0048
768 DEVICE ISSUE 430 0.0048
769 LOWER RESPIRATORY TRACT INFECTION 218 0.0048
770 TASTE DISORDER 97 0.0048
771 BONE PAIN 279 0.0048
772 INTENTIONAL DOSE OMISSION 135 0.0047
773 PROSTATIC SPECIFIC ANTIGEN INCREASED 65 0.0047
774 HAIR TEXTURE ABNORMAL 63 0.0047
775 ASPARTATE AMINOTRANSFERASE INCREASED 250 0.0047
776 GAMMA-GLUTAMYLTRANSFERASE INCREASED 104 0.0047
777 DECREASED APPETITE 1084 0.0047
778 FRACTURE 88 0.0046
779 SKIN DISORDER 155 0.0046
780 GENERAL PHYSICAL HEALTH DETERIORATION 535 0.0046
781 CATARACT 275 0.0046
782 PROCEDURAL PAIN 128 0.0046
783 ILL-DEFINED DISORDER 279 0.0046
784 COLITIS 174 0.0046
785 CYANOSIS 72 0.0046
786 BLISTER 257 0.0046
787 SWELLING FACE 297 0.0046
788 LIP SWELLING 151 0.0045
789 MULTIPLE FRACTURES 74 0.0045
790 ASTHMA 506 0.0045
791 HEPATIC CIRRHOSIS 84 0.0045
792 OFF LABEL USE 3884 0.0044
793 MOOD ALTERED 120 0.0044
794 TARDIVE DYSKINESIA 124 0.0044
795 SECRETION DISCHARGE 55 0.0044
796 GASTROENTERITIS 64 0.0044
797 BLOOD POTASSIUM INCREASED 71 0.0044
798 ABDOMINAL PAIN 1017 0.0044
799 INJECTION SITE ERYTHEMA 542 0.0044
800 HYPOACUSIS 188 0.0044
801 BLOOD COUNT ABNORMAL 66 0.0043
802 TOOTH LOSS 90 0.0043
803 FULL BLOOD COUNT DECREASED 87 0.0043
804 DRUG INEFFECTIVE 5672 0.0043
805 PARAESTHESIA ORAL 62 0.0043
806 PLATELET COUNT INCREASED 56 0.0043
807 PHOTOSENSITIVITY REACTION 70 0.0042
808 THIRST 75 0.0042
809 AKATHISIA 57 0.0042
810 TREATMENT FAILURE 345 0.0042
811 HUNGER 58 0.0042
812 THERAPY INTERRUPTED 296 0.0041
813 PRODUCT USE IN UNAPPROVED INDICATION 1024 0.0041
814 DRUG EFFECT INCOMPLETE 150 0.0041
815 URTICARIA 687 0.0041
816 LUNG DISORDER 200 0.0041
817 HAEMOGLOBIN DECREASED 419 0.0041
818 EXTRA DOSE ADMINISTERED 165 0.0041
819 BRONCHOSPASM 58 0.0041
820 LUNG INFECTION 63 0.0041
821 CEREBROVASCULAR ACCIDENT 685 0.0040
822 DEMENTIA 113 0.0040
823 DEVICE LEAKAGE 175 0.0040
824 ACUTE MYOCARDIAL INFARCTION 119 0.0040
825 HYPERGLYCAEMIA 147 0.0040
826 PRESYNCOPE 98 0.0040
827 LEUKOPENIA 201 0.0040
828 ANAPHYLACTIC REACTION 222 0.0040
829 DRUG PRESCRIBING ERROR 77 0.0040
830 HAEMATURIA 137 0.0040
831 MEDICATION ERROR 221 0.0040
832 BLOOD GLUCOSE ABNORMAL 73 0.0039
833 INJECTION SITE BRUISING 313 0.0039
834 RASH 1709 0.0039
835 PNEUMOTHORAX 62 0.0039
836 LACRIMATION INCREASED 118 0.0039
837 PANCREATITIS 205 0.0039
838 INJURY 271 0.0039
839 RENAL FAILURE ACUTE 162 0.0038
840 PRODUCT ADMINISTRATION ERROR 77 0.0038
841 HYPERTHYROIDISM 55 0.0038
842 CARDIAC DISORDER 355 0.0038
843 DEAFNESS 99 0.0038
844 SHOCK 87 0.0038
845 RASH PRURITIC 204 0.0038
846 PULMONARY OEDEMA 168 0.0037
847 DYSPNOEA EXERTIONAL 141 0.0037
848 DYSGEUSIA 278 0.0037
849 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 265 0.0037
850 RENAL DISORDER 173 0.0037
851 ERYTHEMA 763 0.0037
852 HOSPITALISATION 565 0.0037
853 ACUTE RESPIRATORY DISTRESS SYNDROME 65 0.0037
854 PSORIATIC ARTHROPATHY 149 0.0037
855 PRURITUS GENERALISED 79 0.0036
856 VISUAL ACUITY REDUCED 121 0.0036
857 PALLOR 99 0.0036
858 INJECTION SITE URTICARIA 89 0.0036
859 SKIN CANCER 78 0.0036
860 DEVICE BREAKAGE 147 0.0036
861 ERUCTATION 70 0.0036
862 CONJUNCTIVITIS 67 0.0036
863 RECTAL HAEMORRHAGE 155 0.0036
864 SYSTEMIC LUPUS ERYTHEMATOSUS 128 0.0036
865 RASH ERYTHEMATOUS 172 0.0036
866 ATRIAL FIBRILLATION 349 0.0036
867 DERMATITIS 75 0.0036
868 WRONG TECHNIQUE IN DRUG USAGE PROCESS 130 0.0036
869 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 644 0.0036
870 PERICARDIAL EFFUSION 82 0.0035
871 METABOLIC ACIDOSIS 113 0.0035
872 DRUG-INDUCED LIVER INJURY 110 0.0035
873 PELVIC PAIN 63 0.0035
874 CORONARY ARTERY DISEASE 105 0.0035
875 INCORRECT ROUTE OF DRUG ADMINISTRATION 123 0.0034
876 ANAEMIA 651 0.0034
877 RASH MACULAR 119 0.0034
878 PRODUCT AVAILABILITY ISSUE 77 0.0034
879 MULTI-ORGAN FAILURE 58 0.0034
880 PRODUCT ADHESION ISSUE 118 0.0033
881 BLOOD BILIRUBIN INCREASED 89 0.0033
882 AGEUSIA 82 0.0033
883 PRODUCT USE ISSUE 616 0.0033
884 MOUTH ULCERATION 69 0.0033
885 PRODUCT SUBSTITUTION ISSUE 188 0.0033
886 ADVERSE EVENT 300 0.0033
887 MYOCARDIAL INFARCTION 565 0.0032
888 INTERNATIONAL NORMALISED RATIO INCREASED 92 0.0032
889 DRUG ADMINISTRATION ERROR 99 0.0032
890 INTENTIONAL SELF-INJURY 65 0.0032
891 PULMONARY HYPERTENSION 67 0.0032
892 BLOOD CREATININE INCREASED 210 0.0032
893 RENAL IMPAIRMENT 270 0.0032
894 HEPATIC FAILURE 96 0.0032
895 EYE SWELLING 118 0.0032
896 EMOTIONAL DISTRESS 382 0.0032
897 ISCHAEMIC STROKE 56 0.0031
898 OSTEONECROSIS 103 0.0031
899 RASH PAPULAR 70 0.0031
900 DISEASE PROGRESSION 369 0.0031
901 HAEMATOCHEZIA 172 0.0031
902 ANAPHYLACTIC SHOCK 80 0.0031
903 LIVER DISORDER 137 0.0031
904 EPISTAXIS 230 0.0031
905 GOUT 55 0.0031
906 DRUG DEPENDENCE 490 0.0030
907 CARDIOVASCULAR DISORDER 76 0.0030
908 ABDOMINAL PAIN LOWER 75 0.0030
909 FREQUENT BOWEL MOVEMENTS 80 0.0030
910 CARDIAC FAILURE CONGESTIVE 237 0.0029
911 PRODUCT PRESCRIBING ISSUE 64 0.0029
912 BLOOD GLUCOSE DECREASED 141 0.0029
913 INCREASED APPETITE 56 0.0029
914 PLATELET COUNT DECREASED 310 0.0029
915 HYPOGLYCAEMIA 141 0.0029
916 FAECES DISCOLOURED 63 0.0029
917 MULTIPLE ORGAN DYSFUNCTION SYNDROME 82 0.0029
918 NEUTROPHIL COUNT DECREASED 117 0.0029
919 INTENTIONAL DRUG MISUSE 60 0.0029
920 INJECTION SITE PRURITUS 192 0.0029
921 EXTRAPYRAMIDAL DISORDER 71 0.0029
922 ARRHYTHMIA 135 0.0028
923 CEREBRAL HAEMORRHAGE 102 0.0028
924 ANGINA PECTORIS 81 0.0028
925 BONE DENSITY DECREASED 88 0.0028
926 HAEMOPTYSIS 78 0.0028
927 PRODUCT PHYSICAL ISSUE 56 0.0028
928 GASTROINTESTINAL HAEMORRHAGE 228 0.0027
929 GLOSSODYNIA 61 0.0027
930 SKIN EXFOLIATION 229 0.0027
931 PLEURAL EFFUSION 164 0.0027
932 ECZEMA 140 0.0027
933 PANCREATITIS ACUTE 60 0.0027
934 INJECTION SITE PAIN 818 0.0027
935 PLASMA CELL MYELOMA 104 0.0027
936 LACTIC ACIDOSIS 86 0.0027
937 TRANSAMINASES INCREASED 59 0.0027
938 INJECTION SITE SWELLING 203 0.0026
939 PSORIASIS 345 0.0026
940 PAIN OF SKIN 71 0.0026
941 BREAST CANCER FEMALE 70 0.0026
942 HEPATITIS 66 0.0026
943 ABORTION SPONTANEOUS 103 0.0026
944 JAUNDICE 69 0.0026
945 OCULAR HYPERAEMIA 121 0.0025
946 BLOOD GLUCOSE INCREASED 480 0.0025
947 INJECTION SITE RASH 78 0.0025
948 HYPERKALAEMIA 89 0.0025
949 EYE IRRITATION 146 0.0025
950 DRY SKIN 337 0.0025
951 DISEASE RECURRENCE 120 0.0025
952 RASH GENERALISED 65 0.0025
953 HAEMORRHAGE 262 0.0025
954 BREAST CANCER 231 0.0025
955 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0024
956 ACNE 180 0.0024
957 INCORRECT DOSE ADMINISTERED BY DEVICE 62 0.0024
958 INCORRECT DOSE ADMINISTERED 537 0.0024
959 NEOPLASM MALIGNANT 157 0.0024
960 DEATH 2017 0.0023
961 CARDIAC FAILURE 187 0.0023
962 PRODUCT QUALITY ISSUE 311 0.0023
963 THROMBOCYTOPENIA 254 0.0023
964 NEEDLE ISSUE 66 0.0023
965 DIABETIC KETOACIDOSIS 54 0.0022
966 ASCITES 66 0.0022
967 EYE PRURITUS 75 0.0022
968 INCORRECT DRUG ADMINISTRATION DURATION 61 0.0022
969 INJECTION SITE HAEMORRHAGE 172 0.0022
970 MATERNAL EXPOSURE DURING PREGNANCY 191 0.0021
971 NEUTROPENIA 291 0.0021
972 EXPIRED PRODUCT ADMINISTERED 70 0.0021
973 ANGIOEDEMA 93 0.0021
974 PREMATURE BABY 62 0.0021
975 PANCYTOPENIA 109 0.0019
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 388 0.0019
977 SKIN BURNING SENSATION 135 0.0019
978 VAGINAL HAEMORRHAGE 76 0.0017
979 NO ADVERSE EVENT 311 0.0017
980 SKIN IRRITATION 78 0.0017
981 HEPATIC FUNCTION ABNORMAL 63 0.0017
982 LUNG NEOPLASM MALIGNANT 64 0.0016
983 ACCIDENTAL EXPOSURE TO PRODUCT 144 0.0014
984 COLITIS ULCERATIVE 62 0.0014
985 FEBRILE NEUTROPENIA 85 0.0013
986 EXPOSURE DURING PREGNANCY 79 0.0013
987 FOETAL EXPOSURE DURING PREGNANCY 103 0.0013
988 DERMATITIS ATOPIC 60 0.0011
989 MALIGNANT NEOPLASM PROGRESSION 101 0.0010
990 PROSTATE CANCER 77 0.0010
991 DRUG DOSE OMISSION BY DEVICE 68 0.0009
992 DEVICE DIFFICULT TO USE 55 0.0008
993 PRODUCT STORAGE ERROR 69 0.0008